One of the most challenging aspects of public policy is staying focused on issues that continue on year after year. Most people want to tackle an issue, get it resolved and move on to another project. Trade policy and trade negotiations do not operate that way. The complexity of the issues and the numerous parties involved cause the process to stretch on for years.
The billionth acre of biotech crops will be harvested about October 2, 2005, in the tenth year of commercial biotech crop production. The second billion acres will likely be harvested in only four years as biotech crops continue to spread around the globe.
Corn producer organizations in the Canadian provinces of Ontario, Quebec and Manitoba have filed a complaint with the Canada Border Services Agency alleging injury by subsidized U.S. corn dumped on their markets. This action has rekindled a 20 year ongoing dispute that has not been addressed despite the economic integration of agriculture under the Canada-U.S. Free Trade Agreement (CUSTA) and its successor, NAFTA.
People familiar with agricultural biotechnology remember the decisions a few years ago of some sub-Saharan African countries to reject offers of biotech corn as food aid. The cassava mosaic virus has infected much of the cassava crop in central Africa, a food staple for over 250 million people, and governments are rejecting biotech cassava as a way to combat the impact of the mosaic virus.
Over a year has passed since commercialization of Roundup Ready (RR) hard red spring wheat in the U.S. and Canada was put on indefinite hold over concerns about market acceptance in the two countries and in major wheat importing countries. The continued expansion in production of biotech crops indicates that biotech wheat may have a brighter future in the years ahead.